cfTrack: A Method of Exome-Wide Mutation Analysis of Cell-free DNA to Simultaneously Monitor the Full Spectrum of Cancer Treatment Outcomes Including MRD, Recurrence, and Evolution

PURPOSE: Cell-free DNA (cfDNA) offers a noninvasive approach to monitor cancer. Here we develop a method using whole-exome sequencing (WES) of cfDNA for simultaneously monitoring the full spectrum of cancer treatment outcomes, including minimal residual disease (MRD), recurrence, evolution, and seco...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shuo, Zeng, Weihua, Ni, Xiaohui, Zhou, Yonggang, Stackpole, Mary L., Noor, Zorawar S., Yuan, Zuyang, Neal, Adam, Memarzadeh, Sanaz, Garon, Edward B., Dubinett, Steven M., Li, Wenyuan, Zhou, Xianghong Jasmine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Precision Medicine and Imaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126584/
https://www.ncbi.nlm.nih.gov/pubmed/35149536
http://dx.doi.org/10.1158/1078-0432.CCR-21-1242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126584/
https://www.ncbi.nlm.nih.gov/pubmed/35149536
http://dx.doi.org/10.1158/1078-0432.CCR-21-1242

Ejemplares similares